| Class | Compound | Serotype* | Cell line | References |
| Fusion inhibitors | 1OAN1 | DENV-2 | LLC-MK2 | [49] | | DN59 | DENV-2 | LLC-MK2 | [50] | | Compound 6 | DENV-1-4 | A549, BHK | [51] | | Tetracycline derivates | DENV-2 | BHK | [52] | | Doxorubicin derivate | DENV-1, -2, -3 | Vero, C6/36 | [53] | | NITD448 | DENV-2 | BHK, C6/36 | [54] |
| Glycosidase inhibitors | Castanospermine | DENV-1-4 | BHK | [55, 56] | | | DENV-2 | Huh-7 | [55] | | DNJ | DENV-1 | Mouse neuro 2a cells | [56] | | NN-DNJ | DENV-2 | BHK | [57] | | Alkylated iminocyclitol | DENV-2 | BHK | [58] | | OSL-9511 | DENV-2 | BHK | [59] | | CM-9-78 | DENV-2 | BHK | [60] |
| CBAs | Con A, WGA | DENV-2 | BHK | [43] | | HHA, GNA, UDA | DENV-1-4 | Raji/DC-SIGN, MDDC | [61, 62] | | | DENV-1-4 | Huh-7, U87/DC-SIGN | Unpublished results | | | DENV-1-4 | Raji/L-SIGN, U87/L-SIGN | Unpublished results | | PRM-S | DENV-2 | MDDC | [62] |
| Heparan mimetics | GAG | DENV-2 | Vero | [28] | | Heparin | DENV-2 | Vero | [28, 29] | | | DENV-2 | BHK | [43] | | | DENV-2 | Hepatocytes | [38] | | Suramin | DENV-2 | Vero, BHK | [28, 63] | | PI-88 | DENV-2 | BHK and in mice | [63] | | PPS | DENV-2 | BHK | [63] | | Fucoidan | DENV-2 | BHK | [64] | | Sulfated galactomannan | DENV-1 | C6/36 | [65] | | DL-galactan | DENV-2, -3 | Vero, HepG2 | [66] | | Carrageenan | DENV-2, -3 | Vero, HepG2 | [66, 67] | | α-D-glucan | DENV-2 | BHK | [68] | | Dextran sulfate 8000 | DENV-2 | Hepatocytes, Vero | [66] | | DS (MW > 500,000 Da) | DENV-2 | Raji/DC-SIGN | [61] | | Zosteric acid | DENV-1-4 | LLC-MK2 | [69] |
|
|